Private investment firm Ardian is to acquire a majority stake in the Inula Group, a Belgium-based key player in the herbal remedies market, from Vendis Capital, Dominique Baudoux (Founder & Chairman) and Sergio Calandri (CEO).
StoryChief, a Ghent, Belgium-based provider of a content marketing platform, raised €1m in funding.
Secure Code Warrior, a secure application development company, raised $3.5m in funding.
imec, a Leuven, Belgium-based research and innovation hub for nanoelectronics and digital technology, closed its first fund, at €117m.
SCG Chemicals Co., Ltd, part of the Siam Cement Public Company Limited (SCG), one of the largest integrated petrochemical companies in Thailand and a key industry leader in Asia, which offers a full range of petrochemical products, has joined the Capricorn Sustainable Chemistry Fund (CSCF) as limited partner.
PlayPass, an Antwerp, Belgium-based provider of technology solutions for events, raised €1.9m in funding.
Teamleader, a Ghent, Belgium-based provider of a SaaS platform for CRM, project management and invoicing, closed a Series C funding round of $22m (€18.5M).
POM, an Antwerp, Belgium-based fintech startup advancing invoice payment solutions, raised €830k in funding.
Dobco Medical Systems, a Belgian online medical imaging company, raised €2.2m in funding.
Paris, France-based investment firm BlackFin Capital Partners has closed a fintech venture capital fund, at €180M.
Univercells, a Gosselies, Belgium-based a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics – recombinant proteins and vaccines, closed a €16m ($18.8m) Series B equity financing.
iTeos Therapeutics SA, a Gosselies, Belgium – based biotechnology company developing novel cancer immunotherapies, completed a $75m (€64m) Series B financing.
Cowboy, a Brussels, Belgium-based startup that developed an innovative electric bike for the commuter, raised $3m in seed funding.
A-Mansia Biotech S.A., a Louvain-la-Neuve, Belgium-based microbiome company, secured €13m in funding.
Promethera Biosciences SA, a Mont Saint Guibert, Belgium- and Durham, NC, USA-based innovator in cell-based medicines and liver diseases, raised €9.3mi (approx. $11.5m) through the issuance of convertible bonds.